news

Takeda's Qdenga Approved as India's First Dengue Vaccine

India Takes a Crucial Step in Dengue Prevention, But Challenges Lie Ahead The approval of Takeda's Qdenga as the first dengue vaccine in India marks a significant development in the country's fight against this mosquito borne disease.

With 14. 4 million reported cases and 11,201 deaths worldwide in 2024, including 232,425 cases and 233 deaths in India, effective prevention measures have never been more pressing.

Dengue has become a growing concern in India over the past two decades, with reported cases rising by an astonishing 11 fold.

Read the full story

Read on Gazea →